Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$6.28 - $15.59 $2.58 Million - $6.4 Million
-410,763 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$26.09 - $40.4 $4.25 Million - $6.59 Million
-162,996 Reduced 28.41%
410,763 $13.9 Million
Q1 2021

May 14, 2021

BUY
$33.06 - $56.93 $19 Million - $32.7 Million
573,759 New
573,759 $21.9 Million
Q3 2020

Nov 13, 2020

SELL
$28.43 - $44.67 $503,211 - $790,659
-17,700 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$11.71 - $30.29 $207,267 - $536,133
17,700 New
17,700 $536,000
Q4 2018

Feb 12, 2019

SELL
$9.26 - $16.38 $529,153 - $936,018
-57,144 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $430,865 - $1.05 Million
57,144 New
57,144 $956,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.